Iron Metabolism Disorders Associated With the Severity of Pyogenic Liver Abscess

Zhongyu Han1, Zhenchao Wu2, Han Zhou2

  • 1Department of Laboratory Medicine Peking University Third Hospital Beijing China.

Food Science & Nutrition
|November 24, 2025
PubMed

Insights

Ferritin shows promise as a low-cost biomarker for pyogenic liver abscess (PLA) severity and bacterial liver abscess (BLA) identification. This finding may guide nutritional interventions for PLA management.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Biomarker Discovery

Background:

  • Pyogenic liver abscess (PLA) presents significant morbidity and mortality.
  • Current diagnostic methods for PLA are often slow, costly, and inefficient.
  • The role of iron metabolism, particularly ferritin, in PLA pathogenesis and progression is not well understood.

Purpose of the Study:

  • To identify rapid, low-cost biomarkers for assessing PLA severity.
  • To investigate the correlation between iron metabolism and PLA severity.
  • To evaluate ferritin as a diagnostic marker for severe PLA and bacterial liver abscess (BLA).

Main Methods:

  • Retrospective analysis of 125 PLA patients from the MIMIC-IV database.
  • Validation using an independent cohort of 36 PLA patients from Peking University Third Hospital.
  • Correlation analysis between iron metabolism markers, disease severity, and inflammation.
  • Receiver operating characteristic (ROC) curve analysis for diagnostic efficiency.

Main Results:

  • Iron metabolism disorders were prevalent in PLA patients, correlating with liver dysfunction and inflammation.
  • Ferritin levels were significantly associated with PLA disease severity.
  • Optimal ferritin cut-offs identified: 390 ng/mL for severe PLA and 748 ng/mL for BLA.
  • Ferritin demonstrated independent prognostic value.

Conclusions:

  • Ferritin is a promising multifaceted biomarker for PLA, reflecting disease severity and aiding in early BLA identification.
  • Findings support ferritin's role in assessing PLA and suggest potential for dietary interventions.
  • This research offers a new avenue for cost-effective PLA management and diagnosis.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
170
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
447
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
204
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
291
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
684
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
876